Mechanisms of epithelial repair and remodeling in pulmonary fibrosis
Mechanisms of epithelial repair and remodeling in pulmonary fibrosis
批准号:
10646242
负责人:
Jonathan Andrew Kropski
金额:
$55.07万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-15 至 2025-06-30
关键词:
3-DimensionalAcuteAirAllelesAlveolarAtypical hyperplasiaAutomobile DrivingBasal CellBleomycinCRISPR/Cas technologyCell Differentiation processCell physiologyCellsChronicClinicalDataDiseaseDistalDoseEpithelial CellsEpitheliumExhibitsExtracellular MatrixFamilyFamily StudyFibrosisG-Protein-Coupled ReceptorsGene ExpressionGenesGeneticGenomic approachHumanHuman Cell LineInfluenzaInjuryInterstitial PneumoniaLiquid substanceLungLung diseasesModelingMusMutationOrganoidsOrphanPathogenesisPathologicPathway interactionsPatientsPeripheralPlayPopulationPredispositionProliferatingPulmonary FibrosisRegulationRoleSeriesStructure of parenchyma of lungSyndromeSystemTestingTracheal EpitheliumTransgenic MiceTransgenic OrganismsWorkairway epitheliumalveolar epitheliumcell typecomparison controldirected differentiationepithelial repairepithelium regenerationexome sequencingexperimental studyfibrotic lungin vivoinduced pluripotent stem cellinnovationloss of functionmutantnovelprogramsrare variantreceptorrepairedrisk variantsegregationsingle-cell RNA sequencingstem cell modeltime use
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Pulmonary fibrosis (PF) is a clinical syndrome that represents the end-stage of chronic parenchymal
lung diseases. Dysfunctional repair of the distal lung epithelium has been hypothesized as central to PF
pathogenesis, but the mechanisms governing epithelial repair following injury remain incompletely understood.
In order to comprehensively profile the cell types and gene expression programs driving PF, we performed
single-cell RNA-sequencing (scRNA-seq) of peripheral tissue from PF and control lungs and identified dramatic
changes in cell types, states, and expression programs in PF lung epithelium including a previously
undescribed KRT5-/KRT17+ “distal basal cell” (DBC) population that produces pathologic extracellular matrix.
Independently, using whole-exome sequencing for genetic discovery in families with pulmonary fibrosis
(Familial Interstitial Pneumonia, FIP), we identified rare mutations in an orphan G-protein coupled receptor
(GPR87) that segregate with disease, implicating GPR87 as a novel FIP risk gene. Our preliminary data
indicate that GPR87 gene expression is dramatically increased in lung tissue from patients with sporadic cases
of IPF, and localizes specifically to these newly described pathologic ECM-producing DBCs. In mice, as in
humans, Gpr87 expression was low in the peripheral lung; however, expression increases substantially after
following bleomycin injury, where it localized to distal basal cells. We generated mice expressing an FIP-
associated mutant form of Gpr87 using a CRISPR-Cas9 gene editing strategy and found that mice carrying a
single-copy of the mutation (Gpr87mut/wt) had increased lung fibrosis compared to control mice following a
single-dose bleomycin. Unchallenged mice carrying biallelic mutations (Gpr87mut/mut) develop spontaneous
airway epithelial remodeling and striking atypical hyperplasia in vivo. Consistent with these findings, culture of
Gpr87mut/mut mouse tracheal epithelial cells (MTECs) in air-liquid interface (ALI) and 3D organoid systems
resulted in aberrant epithelial differentiation. Together, our preliminary data implicate DBCs in PF pathogenesis
and suggest that GPR87 regulates the fate and function of these cells. Our hypothesis is that GPR87
regulates proliferation and differentiation of distal basal cells, which are required for efficient repair of alveolar
epithelium after severe or repetitive injury. Our specific aims are: 1) Determine the role of Gpr87-
expressing distal basal cells in promoting lung fibrosis. 2) Identify mechanisms regulating distal
basal cell fate and function in severe and chronic alveolar injury. 3) Investigate GPR87-dependent
regulation of basal cell function and differentiation. In studies proposed below, we will use innovative
transgenic mouse, organoid and inducible pluripotent stem cell (iPSC)-based models to investigate the
mechanisms through which GPR87 contributes to fibrotic susceptibility and adaptive versus pathologic lung
epithelial repair.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1513/annalsats.202303-188ps
发表时间:
2023
期刊:
Annals of the American Thoracic Society
影响因子:
8.3
作者:
[Kim,JohnS, Montesi,SydneyB, Adegunsoye,Ayodeji, Humphries,StephenM, Salisbury,MargaretL, Hariri,LidaP, Kropski,JonathanA, Richeldi,Luca, Wells,AtholU, Walsh,Simon, Jenkins,RGisli, Rosas,Ivan, Noth,Imre, Hunninghake,GaryM, Martinez,]
通讯作者:
Martinez,
Myeloid Cell Derived IL1β Contributes to Pulmonary Vascular Remodeling in Heart Failure with Preserved Ejection Fraction.
骨髓细胞衍生的 IL1β 有助于心力衰竭的肺血管重塑,并保留射血分数。
DOI:
10.1101/2023.05.18.541302
发表时间:
2023
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Agrawal,Vineet, Kropski,JonathanA, Gokey,JasonJ, Kobeck,Elizabeth, Murphy,Matthew, Murray,KatherineT, Fortune,NikiL, Moore,ChristyS, Meoli,DavidF, Monahan,Ken, Su,YanRu, Blackwell,Thomas, Gupta,DeepakK, Talati,MeghaH, Gladson,Santh]
通讯作者:
Gladson,Santh
DOI:
10.1016/j.pharmthera.2020.107798
发表时间:
2021-06
期刊:
Pharmacology & therapeutics
影响因子:
13.5
作者:
[Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, Maher TM, Tzouvelekis A, Ryerson CJ]
通讯作者:
Ryerson CJ
DOI:
10.3389/fmed.2021.752316
发表时间:
2021
期刊:
Frontiers in medicine
影响因子:
3.9
作者:
[Gokey JJ, Patel SD, Kropski JA]
通讯作者:
Kropski JA
Myeloid Cell Derived IL1β Contributes to Pulmonary Hypertension in HFpEF.
骨髓细胞衍生的 IL1β 有助于 HFpEF 中的肺动脉高压。
DOI:
10.1161/circresaha.123.323119
发表时间:
2023
期刊:
Circulation research
影响因子:
20.1
作者:
[Agrawal,Vineet, Kropski,JonathanA, Gokey,JasonJ, Kobeck,Elizabeth, Murphy,MatthewB, Murray,KatherineT, Fortune,NikiL, Moore,ChristyS, Meoli,DavidF, Monahan,Ken, RuSu,Yan, Blackwell,Thomas, Gupta,DeepakK, Talati,MeghaH, Gladson,San]
通讯作者:
Gladson,San
共 6 条
FASEB SRC: The Lung Epithelium Conference: In Health and Disease
-
批准号:10468447
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2022
-
负责人:Jonathan Andrew Kropski
-
依托单位:
Mechanisms of epithelial repair and remodeling in pulmonary fibrosis
-
批准号:10030370
-
项目类别:
-
资助金额:$61.04万
-
财政年份:2020
-
负责人:Jonathan Andrew Kropski
-
依托单位:
Mechanisms of epithelial repair and remodeling in pulmonary fibrosis
-
批准号:10431866
-
项目类别:
-
资助金额:$55.09万
-
财政年份:2020
-
负责人:Jonathan Andrew Kropski
-
依托单位:
Mechanisms of epithelial repair and remodeling in pulmonary fibrosis
-
批准号:10215620
-
项目类别:
-
资助金额:$55.21万
-
财政年份:2020
-
负责人:Jonathan Andrew Kropski
-
依托单位:
Thromboxane Receptor Signaling in Pulmonary Fibrosis
-
批准号:10526417
-
项目类别:
-
资助金额:$53.36万
-
财政年份:2019
-
负责人:Jonathan Andrew Kropski
-
依托单位:
DNA-Damage Repair In Pulmonary Fibrosis
-
批准号:9013893
-
项目类别:
-
资助金额:$3.73万
-
财政年份:2016
-
负责人:Jonathan Andrew Kropski
-
依托单位:
海外基金